Targeting FLT3 phosphorylation and signaling in acute myeloid leukemia.

被引：0
|
作者：
Ikeda, Alan K. [1 ]
Judelson, Dejah [1 ]
Li, Junling [2 ]
Wei, Ru Qi [2 ]
Tapang, Paul [2 ]
Davidsen, Steven K. [2 ]
Albert, Dan H. [2 ]
Glaser, Keith B. [2 ]
Fu, Cecilia [1 ]
Sakamoto, Kathleen M. [1 ,3 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90024 USA
[2] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
[3] CALTECH, Pasadena, CA 91125 USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.912.912
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
912
引用
收藏
页码：278A / 278A
页数：1
相关论文
共 50 条
  • [41] Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia
    Wang, Eunice S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (02) : 154 - 162
  • [42] Differential signaling of Flt3 activating mutations in acute myeloid leukemia:a working model
    Perry M.Chan
    Protein & Cell, 2011, 2 (02) : 108 - 115
  • [43] Differential signaling of Flt3 activating mutations in acute myeloid leukemia: a working model
    Chan, Perry M.
    PROTEIN & CELL, 2011, 2 (02) : 108 - 115
  • [44] Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia
    Lim, Yiting
    Gondek, Lukasz
    Li, Li
    Wang, Qiuju
    Ma, Haley
    Chang, Emily
    Huso, David L.
    Foerster, Sarah
    Marchionni, Luigi
    McGovern, Karen
    Watkins, David Neil
    Peacock, Craig D.
    Levis, Mark
    Smith, Bruce Douglas
    Merchant, Akil A.
    Small, Donald
    Matsui, William
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (291)
  • [45] Xanthohumol as a potential therapeutic strategy for acute myeloid leukemia: Targeting the FLT3/SRPK1 signaling axis
    Zhang, Duan-Na
    Yang, Wen-Ya
    Hu, Xiao-Xue
    Song, Xiao-Min-Ting
    Guo, Chuan-Jie
    Peng, Fu
    Li, Yu-Zhi
    Cao, Zhi-Xing
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2025, 33 (01)
  • [46] Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations
    Radomska, HS
    Bassères, DS
    Zheng, R
    Zhang, P
    Dayaram, T
    Yamamoto, Y
    Sternberg, DW
    Lokker, N
    Giese, NA
    Bohlander, SK
    Schnittger, S
    Delmotte, MH
    Davis, RJ
    Small, D
    Hiddemann, W
    Gilliland, DG
    Tenen, DG
    JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (02): : 371 - 381
  • [47] Natural small molecule triptonide inhibits lethal acute myeloid leukemia with FLT3-ITD mutation by targeting Hedgehog/FLT3 signaling
    Xu, Ying
    Wang, Ping
    Li, Mengyuan
    Wu, Zhaoxing
    Li, Xian
    Shen, Jianping
    Xu, Rongzhen
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
  • [48] Effects of the FLT3 inhibitor PKC 412 in combination with cytostatic drugs in vitro in acute myeloid leukemia.
    Möllgård, L
    Bengtzen, S
    Fioretos, T
    Andersson, A
    Paul, C
    Lehmann, S
    BLOOD, 2004, 104 (11) : 501A - 501A
  • [49] FLT3-targeting TriTACs are T cell engagers for treatment of acute myeloid leukemia.
    Austin, Richard J.
    Aaron, Wade H.
    Barath, Manasi
    Callihan, Evan
    Gatto, Scott
    Hemmati, Golzar
    Law, Che-Leung
    Lemon, Bryan D.
    O'Rear, Jessica
    Patnaik, Purbasa
    Thompson, Morgan
    Lihn To
    Wesche, Holger
    Wright, Kevin
    Xiao, Yinghua
    Yu, Stephen
    Yu, Timothy Z.
    CANCER RESEARCH, 2021, 81 (13)
  • [50] Internal tandem duplication of Flt3 gene is a poor prognostic indicator in pediatric acute myeloid leukemia.
    Meshinchi, S
    Stirewalt, D
    Sweetser, D
    Buckley, JD
    Bernstein, ID
    Radich, JP
    BLOOD, 1999, 94 (10) : 504A - 504A
12345